Afficher la couverture 'Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives | Lagoutte-Renosi, Jennifer' en grand format
/5

0 avis

Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives

Archive ouverte

Lagoutte-Renosi, Jennifer | Allemand, Florentin | Ramseyer, Christophe | Yesylevskyy, Semen | Davani, Siamak

Edité par CCSD ; Elsevier -

International audience. Molecular modeling in pharmacology is a promising emerging tool for exploring drug interactions with cellular components. Recent advances in molecular simulations, big data analysis, and artificial intelligence (AI) have opened new opportunities for rationalizing drug interactions with their pharmacological targets. Despite the obvious utility and increasing impact of computational approaches, their development is not progressing at the same speed in different fields of pharmacology. Here, we review current in silico techniques used in cardiovascular diseases (CVDs), cardiological drug discovery, and assessment of cardiotoxicity. In silico techniques are paving the way to a new era in cardiovascular medicine, but their use somewhat lags behind that in other fields.

Suggestions

Du même auteur

Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite

Archive ouverte | Lagoutte-Renosi, Jennifer | CCSD

International audience. Lipids contained in the plasma membrane of platelets play an important role in platelet function. Modifications in the lipid composition can fluidify or rigidify the environment around embedd...

Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor

Archive ouverte | Haghighi, Fatemeh | CCSD

International audience. The binding of natural ligands and synthetic drugs to the P2Y12 receptor is of great interest because of its crucial role in platelets activation and the therapy of arterial thrombosis. Up to...

Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients

Archive ouverte | Lagoutte-Renosi, Jennifer | CCSD

International audience. Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, now makes it possible to ...

Chargement des enrichissements...